High Density SNP Array Analysis of Tyrosine Kinase Inhibitor (TKI) Resistant Chronic Myeloid Leukemia (CML) Shows Secondary Genomic Alterations

被引：0

作者：

Nowak, Daniel ^{[1
]}

Kawamata, Norihiko ^{[1
]}

Akagi, Tadayuki ^{[1
]}

Okamoto, Ryoko ^{[1
]}

Thoennissen, Nils ^{[1
]}

Hofmann, Wolf-Karsten ^{[2
]}

Kato, Motohiro ^{[3
]}

Haferlach, Torsten ^{[4
]}

Ogawa, Seishi ^{[3
]}

Koeffler, H. Phillip ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Div Hematol & Oncol, Los Angeles, CA USA

[2] Charite, Dept Hematol & Oncol, Berlin, Germany

[3] Univ Tokyo, Tokyo, Japan

[4] MLL Munchner Leukamie Labor GmbH, Munich, Germany

来源：

BLOOD | 2008年 / 112卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1091 / 1092

页数：2

共 50 条

[41] OUTCOME OF BLAST PHASE CHRONIC MYELOID LEUKEMIA (CML-BP) IN THE TYROSINE KINASE INHIBITOR ERA [J].

Talati, C. ;

Isenalumhe, L. ;

Shams, S. ;

Kuykendall, A. ;

Chavez, J. ;

Shah, B. ;

Sweet, K. ;

Pinilla-Ibarz, J. .

HAEMATOLOGICA, 2017, 102 :239-239

[42] Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillance [J].

Imeri, Jusuf ;

Desterke, Christophe ;

Marcoux, Paul ;

Chaker, Diana ;

Oudrhiri, Noufissa ;

Fund, Xavier ;

Faivre, Jamila ;

Bennaceur-Griscelli, Annelise ;

Turhan, Ali G. .

FRONTIERS IN ONCOLOGY, 2023, 13

[43] Venetoclax (VEN) and tyrosine kinase inhibitor (TKI) combinations in Philadelphia chromosome-positive (Ph plus ) acute myeloid leukemia (AML) and chronic myeloid leukemia myeloid blast phase (CML MBP). [J].

Maiti, Abhishek ;

Ravandi, Farhad ;

Cortes, Jorge E. ;

Jabbour, Elias ;

Marx, Kayleigh ;

Daver, Naval Guastad ;

Garcia-Manero, Guillermo ;

Konopleva, Marina ;

Benton, Christopher Brent ;

Masarova, Lucia ;

Dinardo, Courtney Denton ;

Bose, Prithviraj ;

Naqvi, Kiran ;

Pierce, Sherry A. ;

Kantarjian, Hagop M. ;

Short, Nicholas James .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

[44] Health-Related Quality of Life (HRQOL) in Patients (Pts) with Tyrosine Kinase Inhibitor(TKI)-Resistant Chronic Myeloid Leukemia (CML) Receiving Olverembatinib (HQP1351) Therapy [J].

Yu, Lu ;

Men, Lichuang ;

Li, Zongru ;

Huang, Xiaojun ;

Jiang, Qian .

BLOOD, 2023, 142

[45] Discontinuation of Tyrosine Kinase Inhibitor (TKI) Treatment in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in US Clinical Practice Following Updates to NCCN CML Practice Guidelines [J].

Atallah, Ehab ;

Sadek, Islam ;

Maegawa, Rodrigo ;

Cao, Xiting ;

Latremouille-Viau, Dominick ;

Pivneva, Irina ;

Rossi, Carmine ;

Guerin, Annie ;

Kota, Vamsi .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 :S231-S231

[46] Discontinuation of tyrosine kinase inhibitor (TKI) therapy in chronic myeloid leukemia in chronic phase (CML-CP) in US clinical practice after guideline updates. [J].

Atallah, Ehab L. ;

Sadek, Islam ;

Maegawa, Rodrigo O. ;

Cao, Xiting ;

Latremouille-Viau, Dominick ;

Pivneva, Irina ;

Rossi, Carmine ;

Guerin, Annie ;

Kota, Vamsi .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

[47] Symptoms Following Discontinuation of Tyrosine Kinase Inhibitor (TKI) Therapy After Achieving an Adequate Response in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) [J].

Ritchie, Ellen K. ;

Sadek, Islam ;

Pivneva, Irina ;

Guerin, Annie ;

Latremouille-Viau, Dominick ;

Ndife, Briana ;

Joseph, George J. ;

Atallah, Ehab L. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 :S221-S222

[48] The tyrosine kinase inhibitor (TKI) imatinib produces mast cell deficiency in Ph plus chronic myeloid leukemia [J].

Cerny-Reiterer, S. ;

Herndlhofer, S. ;

Stefanzl, G. ;

Blatt, K. ;

Hoermann, G. ;

Muellauer, L. ;

Beham-Schmid, C. ;

Baumgartner, S. ;

Sperr, W. S. R. ;

Mannhalter, C. ;

Linkesch, W. ;

Valent, P. .

ONKOLOGIE, 2013, 36 :63-63

[49] US Expert Consensus on Defining Intolerance to Tyrosine Kinase Inhibitor Treatment in Chronic Phase Chronic Myeloid Leukemia (CML) [J].

Atallah, Ehab L. ;

Broder, Michael S. ;

Chan, Onyee ;

Dalglish, Hannah ;

Flynn, Kathryn E. ;

Gilreath, Jeffrey ;

Hine, Marisa ;

Hunter, Anthony M. ;

Mauro, Michael J. ;

Pinilla-Ibarz, Javier ;

Rein, Lindsay A. M. ;

Shah, Neil P. ;

Stemper, Evan ;

Tantravahi, Srinivas K. ;

Yang, Jay .

BLOOD, 2024, 144 :5052-5054

[50] Estimated Glomerular Filtration Rate Changes In Patients (Pts) With Chronic Myeloid Leukemia (CML) Treated With Tyrosine Kinase Inhibitors (TKI) [J].

Yilmaz, Musa ;

Kantarjian, Hagop M. ;

Quintas-Cardama, Alfonso ;

O'Brien, Susan ;

Burger, Jan A. ;

Ferrajoli, Alessandra ;

Borthakur, Gautam ;

Ravandi, Farhad ;

Pierce, Sherry ;

Jabbour, Elias ;

Cortes, Jorge E. .

BLOOD, 2013, 122 (21)

← 1 2 3 4 5 →